For the last eight years, Leslie MacGregor from Newton, Massachusetts, has been getting intravenous infusions every month. The treatment is called immunoglobulin, and it bolsters her defective immune ...
Findings showed after 52 weeks, significant improvements in 2MWD and 6MWD were seen with Flebogamma 5% DIF 1mg/kg compared with placebo. Topline data were announced from a phase 2/3 trial evaluating ...
In a recent study posted to the medRxiv* preprint server, researchers comparatively evaluated antibody (Ab) responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among ...
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing neuropathy likely caused by an autoimmune attack on the peripheral nerves. A number of treatment trials ...
US-based Memorial Hermann Health System has partnered with KabaFusion to offer its home infusion therapy services for individuals with chronic conditions. This collaboration also aims to provide the ...
Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...
In recent years, we have witnessed an alarming shortage of IVIg, first encountered during the late 1990s, with demand exceeding supply by about 20% in 1997 and by 30% in 1998. 2 There are several ...
After being found effective over longer durations with smaller doses, this study found that nipocalimab infusions resulted in a tolerable safety profile and remained effective even in shorter ...
KYOTO, Japan — Subcutaneous (SC) immunoglobulin offers several benefits compared with intravenous (IV) infusion as maintenance treatment for chronic inflammatory demyelinating polyneuropathy (CIDP), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results